These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19977039)

  • 1. Acromegaly: Pituitary Tumour showing the Failure of the Fields for Colour before the Failure of the White Field.
    Doyne RW
    Proc R Soc Med; 1913; 6(Neurol Sect):xxviii-xxx. PubMed ID: 19977039
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
    Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide use for rescue of vision in a pregnant patient with acromegaly.
    Hannon AM; Frizelle I; Kaar G; Hunter SJ; Sherlock M; Thompson CJ; O'Halloran DJ;
    Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31117051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly.
    Hennessey JV; Jackson IM
    Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):271-314. PubMed ID: 7625986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum growth hormone levels and size of pituitary tumour in untreated acromegaly.
    Wright AD; McLachlan MS; Doyle FH; Fraser TR
    Br Med J; 1969 Dec; 4(5683):582-4. PubMed ID: 5356545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours.
    Iacovazzo D; Chiloiro S; Carlsen E; Bianchi A; Giampietro A; Tartaglione T; Bima C; Bracaccia ME; Lugli F; Lauretti L; Anile C; Gessi M; Colosimo C; Rindi G; Pontecorvi A; Korbonits M; De Marinis L
    Endocrine; 2020 Mar; 67(3):651-658. PubMed ID: 31875303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acromegaly: report of two patients with an unusual presentation.
    Castro Cabezas M; Zelissen PM; Jansen GH; Van Gils AP; Koppeschaar HP
    Neth J Med; 1999 Apr; 54(4):163-6. PubMed ID: 10218386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
    Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial acromegaly: a familial report and review of the literature.
    Tiryakioğlu O; Caneroğlu NU; Yilmaz E; Gazioğlu N; Kadioğlu P; Açbay O; Gündoğdu S
    Endocr Res; 2004 May; 30(2):239-45. PubMed ID: 15473133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour.
    Kasperlik-Zaluska AA; Wislawski J; Kaniewska J; Zborzil J; Frankiewicz E; Zgliczyński S
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):347-9. PubMed ID: 3687320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Open-and-close' pituitary surgery in an acromegalic man presenting with excessive sweatiness.
    Cheung KK; Chow FC; Lo AW
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27284097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart failure as a manifestation of acromegaly].
    Ságová I; Dragula M; Kantárová D; Vaňuga A; Vaňuga P
    Vnitr Lek; 2020; 66(4):82-86. PubMed ID: 32972190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
    Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
    Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral testicular enlargement and seminoma in a patient with acromegaly.
    Abraham D; Couldwell WT
    Br J Neurosurg; 2004 Dec; 18(6):629-31. PubMed ID: 15799199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly and pluriglandular dysfunction showing calcification of pituitary.
    KAHAN A
    Proc R Soc Med; 1948 Oct; 41(10):655. PubMed ID: 18121375
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of selective pituitary adenomectomy to cure acromegaly.
    Mims RB; Weiss MH
    J Natl Med Assoc; 1977 May; 69(5):295-9. PubMed ID: 864768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary insufficiency and regression of acromegaly caused by pituitary apoplexy following cerebral angiography.
    Louwerens M; de Herder WW; Postema PT; Tanghe HL; Lamberts SW
    Eur J Endocrinol; 1996 Jun; 134(6):737-40. PubMed ID: 8766945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly.
    Amato G; Mazziotti G; Rotondi M; Iorio S; Doga M; Sorvillo F; Manganella G; Di Salle F; Giustina A; Carella C
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):65-71. PubMed ID: 11849248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
    Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.